Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2269-2272

  Ke, Pan ^a   Wu, Zhong De ^a   Wen, Hua Song ^a   Ying, Miao Xiong ^a   Long, Huo Cheng ^a   Qing, Liu Guo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Digestive cancer; Ethnic variation; Meta analysis; MMP 7; Polymorphism

Indexed keywords

EID: 84880281925     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2269     Document Type: Article

References (23)

1. Bo P, Lihuan C, Xiaopin M, et al (2010). Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis, 25, 371-9.
2. de Lima JM, de Souza LG, da Silva ID, et al (2009). E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer. Int J Biol Markers, 24, 99-106.
3. Dziki L, Przybylowska K, Majsterek I, et al (2011). A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer. Pol Przegl Chir, 83, 622-6.
4. Fang W-L, Liang W-B, He H, et al (2010). Association of Matrix Metalloproteinases 1, 7, and 9 Gene Polymorphisms with Genetic Susceptibility to Colorectal Carcinoma in a Han Chinese Population. DNA Cell Biol, 29, 657-61.
5. Ghilardi G, Biondi ML, Erario M, et al (2003). Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem ,49, 1940-2.
6. Greenwald RJ, Oosterwegel MA, Van der Woude D, et al (2002). CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol, 32, 366-73.
7. Hodi FS, Mihm MC, Soiffer RJ, et al (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA, 100, 4712-17.
8. Jormsjo S, Whatling C, Walter DH, et al (2001). Allele specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol, 21, 1834-39.
9. Kim JH, Pyun JA, Lee KJ, et al (2011). [Study on association between single nucleotide polymorphisms of MMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis]. Korean J Gastroenterol, 58, 245-51.
10. Kubben FJGM, Sier CFM, Meijer MJW, et al (2006). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer, 95, 744-51.
11. Li JY, Tian MM, Zhao AL (2008). Polymorphism in the promoter region of the metalloproteinase-7 increases susceptibility and risk of metastasis of gastric adenocarcinoma. Gastroenterology, 134, A603.
12. Li Y, Jin X, Kang S, et al (2006). Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol, 101, 92-6.
13. Lievre A, Milet J, Carayol J, et al (2006). Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer, 6, 270.
14. Malik MA, Sharma KL, Zargar SA, et al (2011). Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley. Saudi J Gastroenterol, 17, 301-6.
15. Malik MA, Zargar SA, Mittal B (2011). Role of the metalloproteinase-7 (181A>G) polymorphism in gastric cancer susceptibility: a case control study in Kashmir valley. Asian Pac J Cancer Prev, 12, 73-6.
16. Ohtani H, Maeda N, Murawaki Y (2009). Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNF- alpha genes, and the risk of colorectal neoplasm in Japanese. Yonago Acta Medica, 52,47-56
17. Qiu W, Zhou G, Zhai Y, et al (2008). No association of MMP- 7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomarkers Prev, 17, 2514-8.
18. Singh H, Jain M, Mittal B (2008). MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol, 110, 71-5.
19. Sugimoto M, Furuta T, Kodaira C, et al (2008). Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol, 43,751-61.
20. Vairaktaris E, Serefoglou Z, Yapijakis C, et al (2007). High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res, 27, 2493-8.
21. Woo M, Park K, Nam J, et al (2007). Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol, 22, 1064-70.
22. Wu S, Lu S, Tao H, et al (2011). Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer. J Huazhong Univ Sci Technol, 31, 114-9.
23. Zhang J (2005). The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis, 26, 1748-53.